---
category: news
title: "Accutar Biotechnology Receives NMPA Clearance of IND Application for AC0682 in ER-Positive Breast Cancer"
excerpt: "Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces that the China National Medical Products Administration (NMPA) has cleared the company's"
publishedDateTime: 2022-04-01T23:07:00Z
originalUrl: "https://www.lelezard.com/en/news-20317183.html"
webUrl: "https://www.lelezard.com/en/news-20317183.html"
type: article
quality: 7
heat: 7
published: false

provider:
  name: Le LÃ©zard
  domain: lelezard.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.lelezard.com/img/pr_sections/health.jpg"
    width: 640
    height: 480
    isCached: true

secured: "R/a22pzYcNIm5fMWx0bS19FxM7ihz7N6H1obllk5xxH95CBbB+H6gn2WdQSJBbiaksVPn1qUtFFodACMwJDSwC1A8uY8002q/P4zBLY8GozrW7pcSOp4tKn4xqvaLksmFIbXgPzxNUQJpAFwUW72jiokkurhPx+OLWMlEtm58Hhh411QNRS/ojNY9qkMNy6kZFAgiEwlGWrDpo/RqLXFbRKgiGk/hx2bMCdup1HrBiFoCWOPhPvC29A7O7mJWLIJLNcH8bPbz5YmKPNo8ehpXArmlq5MgkfAFwYEIQXIY3zyuYJRUCgFr0RRlwC+q9NDLC0avp+ctWwgW6QrE2CNvTwopMRxmJq4rPhb5cU1bdg=;WIIHMCUjhFUYm4GxgGDqWA=="
---

